NetworkNewsBreaks – Neutra Corp. (NTRR) Establis
Post# of 70
Neutra (OTCQB: NTRR), an early-stage research and development company, is diligently working to establish its position within the increasing hemp-based product and CBD markets. A recent article discussing the company reads, “Neutra is working to establish its position in the particularly lucrative CBD market. According to industry forecasts, hemp-based product sales could reach $22 billion by 2022. Several factors contribute to the growth, including rapid legalization, higher levels of consumer awareness and significantly more research being conducted into the health benefits of CBD. . . . The range of CBD products is constantly growing. Currently, it includes oils, creams, supplements, analgesics, beverages, edibles and various others. CBD can also be inhaled to deliver anti-depression benefits, anti-inflammatory effects, pain relief and relief from the symptoms of neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. Unlike other compounds, CBD does not cause addiction. It also avoids the typical high that stems from THC use.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer